PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE

Post-LOE

promethazine hydrochloride; codeine phosphate

Molecular Devices

ANDAORALSYRUP

Approved

Mar 2010

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE (promethazine hydrochloride; codeine phosphate) by Molecular Devices is mu-opioid receptor, but with a much weaker affinity than morphine. Approved for adenoidectomy [ see. First approved in 2010.

Drug data last refreshed 19h ago

Mechanism of Action

mu-opioid receptor, but with a much weaker affinity than morphine. The analgesic and antitussive properties of codeine have been speculated to come from its conversion to morphine. The precise mechanism of action of codeine and other opiates is not known; however, codeine is believed to act…

Indications (1)

adenoidectomy [ see

Worked on PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.